Dr. Pham Thi My Lien, president of GSK Vietnam, spoke with VIR’s Bich Thuy about the importance of adult vaccinations, one of ...
A new report says that 13 percent of cancers are linked to bacteria or viruses. Vaccines and treatments offer powerful ...
The Food and Drug Administration had recently approved a new drug for the treatment of atopic dermatitis (eczema), which can ...
US FDA approves anti-CD38 therapy, Sarclisa in combo with standard-of-care treatment for adult patients with NDMM who are not eligible for transplant: Paris Tuesday, September 24, ...
DFI therapy cost the UK’s NHS up to £962 million ($1.27 billion) each year. In the U.S., amputation cost alone is $1.38 ...
"I'm a nurse, and I thought there could be a way to detect a potential urinary tract infection earlier for patients wearing ...
Illuminating the experience of people living with sickle cell could improve patients’ lives and enhance all of medicine ...
We’re still asking people with COVID to jump through far too many hoops to get their hands on Pfizer Inc.’s Paxlovid.” ...
The incidence of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis increases with age.1 Despite this trend, ...
Lenacapavir, a new HIV prevention drug, has proven to dramatically reduce the risk of infection according to data reported ...
The Food and Drug Administration (FDA) has expanded the approval of Bimzelx ® (bimekizumab-bkzx) to include 3 new indications. In addition to plaque psoriasis, Bimzelx, a humanized interleukin-17A and ...
Adbry ® (tralokinumab-ldrm) 300 mg/2 mL single-dose autoinjector in the United States. Adbry is currently indicated in the U.S. for patients 12 years and older with moderate-to-severe atopic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback